Join the Zelnorm group to help and get support from people like you.
Zelnorm News
FDA Approves the Reintroduction of Zelnorm (tegaserod) for Irritable Bowel Syndrome with Constipation (IBS-C) in Women Under 65
LOUISVILLE, Ken., April 1, 2019 /PRNewswire/ – US WorldMeds has announced that Sloan Pharma, S.a.r.l., a subsidiary of US WorldMeds Holdings, LLC, has received approval from the U.S. Food and Drug...
FDA Medwatch Alert: Zelnorm (tegaserod maleate)
[Posted 03/30/2007] FDA notified healthcare professionals and patients that Novartis has agreed to discontinue marketing Zelnorm, a drug used for the short-term treatment of women with irritable...
FDA Medwatch Alert: Zelnorm (tegaserod maleate)
The FDA and Novartis notified healthcare professionals of an important drug warning and prescribing information for Zelnorm, a serotonin 5-HT4 receptor partial agonist indicated for the short-term...
Ask a question
To post your own question to this support group, sign in or create an account.